- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05021302
Differences in the Effectiveness of Electromagnetic Stimulation Therapy and Kegel Exercises Based on Compliance, Subjective - Objective Symptoms and Pelvic Floor Muscle Strength in Postpartum Stress Urinary Incontinence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We evaluate the compliance rate, effectiveness (UDI-6 and 1-hour pad test), and pelvic muscle strength of electromagnetic stimulation on stress urinary incontinence compared with Kegel pelvic floor muscle exercises in post-partum women as conservative therapy. This was a Single-blind randomized clinical trial in 40 post-partum women diagnosed with stress urinary incontinence from at least three months post-partum from March 2020 to February 2021 at YPK Mandiri Jakarta Hospital. We recruited consecutively for 40 patients divided into two groups based on type I error of 5% and type II error of 10%. The study population included all post-partum patients diagnosed with SUI over three months. Subjects that are included were signed an informed consent form, post-partum women aged 20 years or over with a diagnosis of stress urinary incontinence since three months post-partum, found a urine leakage when coughing when the bladder volume was 200 to 250 ml, and was able to perform a pad test 1 hour. The study subjects were excluded if the subject complained of mixed incontinence, uncontrolled diabetes mellitus, grade 3 and 4 pelvic organ prolapse, chronic degenerative disease/trauma that affected muscle and nerve function, previous history of pelvic surgery, or a pacemaker. Then, the patients were randomly selected using a computer, namely simple randomization for treatment (Kegel muscle exercises or electromagnetic stimulation).
Kegel exercises had to be done every day for eight weeks. The kegel exercise consisted of two types of training. The first one is contracting and relaxing the fast-twitch muscle. Subjects contracted their muscle for two seconds and followed by four seconds of resting. The next part of the training was for slow-twitch muscles. Subjects needed to contract their pelvic muscle for five seconds and followed by ten seconds rest. All of the training was done alone, five times/set and five sets/day. The time took for a session is approximately two minutes, and it took ten minutes to complete the exercise. To evaluate the patient's compliance, a self-written control card and interview were used, with follow-up every two weeks.
Meanwhile, for those who received an electromagnetic stimulation chair, the patient sat on a magnetic chair with their perineum on the center allow the maximum effect of the magnetic field on the pelvic floor and sphincter muscles. We used NOVAMAG NT-60 chair (NOVAMedtek, Turkey) for our electromagnetic stimulation regiment. The Electromagnetic stimulation consists of 15 sessions with 20 minutes duration and three times a week for five weeks. At the end of each session, subjects were also asked to fill out a control card as proof of attendance. Subjects that were unable to complete 80% of the intended therapy regiment would be classified as not compliant.
Subjects' pelvic floor muscle strength was measured using Peritron by an obstetrician before and after the intervention. To measure their pelvic floor muscle, the patient was asked to contract the pelvic floor muscles and tightly hold for 2 to 3 seconds. Three experiments will be conducted with a break of 10 seconds between contractions, and the value taken is the highest measurement value. Physicians that evaluated the pelvic floor muscle strength will be blinded for the group allocation to reduce bias.
The UDI-6 questionnaire had been translated back and forth and validated. A reduction in the UDI-6 score is treated as a positive result or an improvement of symptoms. 1-hour pad test was used to evaluate their symptoms objectively. Based on the Committee International Continence Society (ICS), an increase of pad weight by 2-10 grams classified as light SUI, 10-50 grams as medium SUI, ≥50 grams as severe SUI. We evaluate all the subjects' symptoms before and after the therapy sessions. Physicians that evaluated the UDI-6 and 1-hour pad test will be blinded for the group allocation to reduce bias.
The dropout criteria of both groups are subjects who do not fill out the control card for at least one week consecutively. Patients are compliant when they attend or done 80% of the intended regimens of therapy.
Subjects' characteristics were summarized using descriptive statistics. Parametric or Non-parametric tests were done appropriately to the normality test of the sample. We used SPSS statistics 21.0 for data analysis and the cut-off for statistical significance of 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jakarta
-
Jakarta Pusat, Jakarta, Indonesia, 10350
- RS YPK Mandiri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- postpartum women aged 20 years or over with a diagnosis of stress urinary incontinence three months postpartum
- signed an informed consent form
- a urine leakage when coughing with bladder volume 200 to 250 ml
- able to perform a pad test 1-hour
Exclusion Criteria:
- uncontrolled diabetes mellitus
- grade 3 and 4 pelvic organ prolapse
- mixed incontinence in the patient
- chronic degenerative disease/trauma that affected muscle and nerve function
- previous history of pelvic surgery
- pacemaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Kegel exercises group
20 women in this group
|
Self-supporting pelvic floor muscle strengthening exercises performed at home by contracting and relaxing quickly (2 seconds of contraction and 4 seconds of rest), followed by a slow contraction (contraction for 5 seconds, and rest for 10 seconds with five times each) five sets per day.
The average length of exercise for each session is 2 minutes, with total exercise per day is 50 times.
Thus, the total length of exercise is 10 minutes.
It was done every day for eight weeks.
Other Names:
|
|
EXPERIMENTAL: Electromagnetic stimulation group
20 women in this group
|
The Electromagnetic stimulation consists of 15 sessions with 20 minutes duration and three times a week.
The total length of therapy is five weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance
Time Frame: five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
Patients are compliant when they attend or done 80% of the intended regimens of therapy.
|
five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
|
UDI-6 Questionnaire
Time Frame: five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
Symptoms reduction
|
five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
|
Symptoms reduction
Time Frame: five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
1-hour pad test
|
five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
|
Pelvic floor muscle strength
Time Frame: five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
Measured by Peritron
|
five weeks for Electomagnet stimulation, eight weeks for Kegel Exercises
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Lim R, Lee SW, Tan PY, Liong ML, Yuen KH. Efficacy of electromagnetic therapy for urinary incontinence: A systematic review. Neurourol Urodyn. 2015 Nov;34(8):713-22. doi: 10.1002/nau.22672. Epub 2014 Sep 22.
- Fujishiro T, Enomoto H, Ugawa Y, Takahashi S, Ueno S, Kitamura T. Magnetic stimulation of the sacral roots for the treatment of stress incontinence: an investigational study and placebo controlled trial. J Urol. 2000 Oct;164(4):1277-9.
- Stewart F, Berghmans B, Bo K, Glazener CM. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD012390. doi: 10.1002/14651858.CD012390.pub2.
- Peng L, Zeng X, Shen H, Luo DY. Magnetic stimulation for female patients with stress urinary incontinence, a meta-analysis of studies with short-term follow-up. Medicine (Baltimore). 2019 May;98(19):e15572. doi: 10.1097/MD.0000000000015572.
- Cacciari LP, Dumoulin C, Hay-Smith EJ. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a cochrane systematic review abridged republication. Braz J Phys Ther. 2019 Mar-Apr;23(2):93-107. doi: 10.1016/j.bjpt.2019.01.002. Epub 2019 Jan 22.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-05-0561
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Urinary Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of ValenciaCompletedFemale Stress Incontinence
-
Watkins Conti Products. Inc.University of OklahomaCompletedStress Incontinence, FemaleUnited States
Clinical Trials on Kegel Exercises
-
Istanbul UniversityCompletedStress Urinary IncontinenceTurkey
-
Istanbul University - Cerrahpasa (IUC)Ondokuz Mayıs UniversityCompletedUrinary Incontinence | Sleep Quality | Postmenopausal SymptomsTurkey
-
The Affiliated Hospital of Putian UniversityNot yet recruiting
-
Cairo UniversityCompleted
-
merve yilmaz menekIstanbul Medipol University HospitalCompletedPostpartum | Postpartum Pelvic Floor Function and Symptoms | Flatus | Pelvic Floor AwarenessTurkey
-
National Institute of Diabetes and Digestive and...Completed
-
Zohra Institute of Health SciencesCompletedUrinary Incontinence in Geriatric PopulationPakistan
-
Superior UniversityActive, not recruitingUrinary IncontinencePakistan
-
Indonesia UniversityRecruitingStress Urinary IncontinenceIndonesia
-
Riphah International UniversityCompleted